India Pesticides profit and loss

Latest FY26

Revenue: ₹1,057cr+27.6% on FY25
EBITDA: ₹174cr+45.1% on FY25
Net profit: ₹120cr+45.8% on FY25
EPS: ₹10.40+45.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,034	1,057	829	680	885	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	16.1	21.0	14.8	15.1	13.2
	1,050	1,078	843	696	898
	632	616	474	378	553
	−79.7	−35.3	−15.5	19.8	−68.2
	66.6	63.6	53.3	42.3	35.5
	8.3	7.4	4.8	4.4	7.2
	21.9	21.3	18.2	15.1	11.4
	251	240	197	153	168
	900	913	732	613	707
	164	174	120	86.6	197
	142	152	101	71.5	186
Profit
	150	166	111	82.3	192
	150	166	111	82.3	192
	36.5	38.2	27.6	17.9	46.4
	5.4	7.8	1.6	4.3	2.1
	41.9	46.0	29.2	22.1	48.4
	108	120	82.2	60.2	143
	108	120	82.2	60.2	143
	0.5	0.4	−0.0	0.2	0.3
	108	120	82.1	60.4	144
	108	120	82.2	—	143
	0.0	0.0	0.0	—	0.0
Per share
	₹9.35	₹10.40	₹7.14	₹5.24	₹12.46
	₹9.35	₹10.40	₹7.14	₹5.24	₹12.46
Revenue detail — as filed
	—	0.0	0.0	0.6	0.0
Other comprehensive income — detail
	0.5	0.4	−0.0	—	—
	0.7	0.6	−0.1	0.3	0.4
	0.2	0.1	−0.0	—	—
	—	—	—	0.1	0.1
	108	120	82.2	—	143
	0.0	0.0	0.0	—	0.0
Per share — as-filed variants
	₹9.35	₹10.40	₹7.14	₹5.24	₹12.46
	₹9.35	₹10.40	₹7.14	₹5.24	₹12.46
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	482	477	370	282	400
	46.6%	45.1%	44.6%	41.5%	45.2%
Adjusted (ex-exceptional items) — derived
	150	166	111	82.3	192
	108	120	82.2	60.2	143
	₹9.35	₹10.40	₹7.14	₹5.24	₹12.46

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IPL₹116.50

India Pesticides Limited

· Chemicals

Annual Quarterly₹ CrorePeersMOL INSECTICID PUNJABCHEM ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,342 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	884.9	680.4	828.6	1,057.4	1,034.0
Other Income	13.2	15.1	14.8	21.0	16.1
Total Income	898.2	695.6	843.4	1,078.4	1,050.1
Expenses
+ Cost of Materials Consumed	553.2	378.3	474.3	615.7	632.0
+ Changes in Inventories	-68.2	19.8	-15.5	-35.3	-79.7
+ Employee Benefit Expense	35.5	42.3	53.3	63.6	66.6
+ Finance Costs	7.2	4.4	4.8	7.4	8.3
+ Depreciation & Amortisation	11.4	15.1	18.2	21.3	21.9
+ Other Expenses	167.6	153.5	197.0	240.0	251.4
Total Expenses	706.5	613.3	732.1	912.5	900.4
EBITDA	196.9	86.6	119.6	173.5	163.8
EBIT	185.6	71.5	101.4	152.3	141.9
Profit
PBT before Exceptional Items	191.6	82.3	111.4	165.9	149.6
Pretax Income	191.6	82.3	111.4	165.9	149.6
+ Current Tax	46.4	17.9	27.6	38.2	36.5
+ Deferred Tax	2.1	4.3	1.6	7.8	5.4
Tax Expense	48.4	22.1	29.2	46.0	41.9
Net Income	143.2	60.2	82.2	119.8	107.7
+ Net Income — Continuing Ops	143.2	60.2	82.2	119.8	107.7
+ Other Comprehensive Income	0.3	0.2	-0.0	0.4	0.5
Total Comprehensive Income	143.5	60.4	82.1	120.2	108.2
Net Income to Common	143.2	—	82.2	119.8	107.6
Minority Interest	0.0	—	0.0	0.0	0.0
Per Share
Basic EPS	12.46	5.24	7.14	10.40	9.35
Diluted EPS	12.46	5.24	7.14	10.40	9.35
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	0.0	0.6	0.0	0.0	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.0	0.4	0.5
+ Items NOT to be Reclassified to P&L	0.4	0.3	-0.1	0.6	0.7
+ Tax on Items NOT to be Reclassified	—	—	-0.0	0.1	0.2
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.1	—	—	—
Comprehensive Income — Owners of Parent	143.2	—	82.2	120.2	108.2
Comprehensive Income — Non-controlling Interests	0.0	—	0.0	0.0	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	12.46	5.24	7.14	10.40	9.35
Diluted EPS — Continuing Operations	12.46	5.24	7.14	10.40	9.35
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	400.0	282.3	369.8	477.1	481.7
Gross Margin %	45.20	41.49	44.63	45.12	46.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	191.6	82.3	111.4	165.9	149.6
Net Income Adj (tax-effected)	143.2	60.2	82.2	119.8	107.7
EPS Adj	12.46	5.24	7.14	10.40	9.35
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	11.5	11.5	11.5	11.5	11.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.